{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:23:23Z","timestamp":1793827403852,"version":"4.6.1"},"reference-count":311,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,15]],"date-time":"2020-06-15T00:00:00Z","timestamp":1592179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["PRIN 2017WC8499_004"],"award-info":[{"award-number":["PRIN 2017WC8499_004"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02362288"],"award-info":[{"award-number":["RF-2016-02362288"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF-2016-02364388"],"award-info":[{"award-number":["RF-2016-02364388"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["GR-2013-02356568"],"award-info":[{"award-number":["GR-2013-02356568"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["5x1000 2015"],"award-info":[{"award-number":["5x1000 2015"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["16764"],"award-info":[{"award-number":["16764"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["20312"],"award-info":[{"award-number":["20312"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["19920"],"award-info":[{"award-number":["19920"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21724"],"award-info":[{"award-number":["21724"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["21147"],"award-info":[{"award-number":["21147"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["800924"],"award-info":[{"award-number":["800924"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","award":["H2020-MSCA-ITN-2017-765104"],"award-info":[{"award-number":["H2020-MSCA-ITN-2017-765104"]}],"id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.mam.2020.100870","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T07:44:41Z","timestamp":1597304681000},"page":"100870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":249,"special_numbering":"C","title":["NK cells and ILCs in tumor immunotherapy"],"prefix":"10.1016","volume":"80","author":[{"given":"Simona","family":"Sivori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Pende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Quatrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pietra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariella","family":"Della Chiesa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Tumino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Mingari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2020.100870_bib1","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2018.01869","article-title":"Natural killer cells: development, maturation, and clinical utilization","volume":"9","author":"Abel","year":"2018","journal-title":"Front. Immunol."},{"issue":"15","key":"10.1016\/j.mam.2020.100870_bib2","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2014-09-599423","article-title":"Gammadelta T-cell reconstitution after HLA-haploidentical hematopoietic transplantation depleted of TCR-alphabeta+\/CD19+ lymphocytes","volume":"125","author":"Airoldi","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib3","doi-asserted-by":"crossref","first-page":"7658","DOI":"10.4049\/jimmunol.178.12.7658","article-title":"Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells","volume":"178","author":"Alter","year":"2007","journal-title":"J.\u00a0Immunol."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib4","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1002\/eji.201445326","article-title":"IL-1beta inhibits ILC3 while favoring NK-cell maturation of umbilical cord blood CD34(+) precursors","volume":"45","author":"Ambrosini","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib5","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cell.2018.10.014","article-title":"Anti-NKG2A mAb is a checkpoint inhibitor that promotes anti-tumor immunity by unleashing both T and NK cells","volume":"175","author":"Andre","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib6","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.semcancer.2006.07.005","article-title":"Tumor and viral recognition by natural killer cells receptors","volume":"16","author":"Arnon","year":"2006","journal-title":"Semin. Canc. Biol."},{"issue":"7534","key":"10.1016\/j.mam.2020.100870_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nature14189","article-title":"The biology of innate lymphoid cells","volume":"517","author":"Artis","year":"2015","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib8","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1111\/ajt.15658","article-title":"Pretransplant adaptive NKG2C+ NK cells protect against cytomegalovirus infection in kidney transplant recipients","volume":"20","author":"Ataya","year":"2020","journal-title":"Am. J. Transplant."},{"issue":"17","key":"10.1016\/j.mam.2020.100870_bib9","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.mam.2020.100870_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.exphem.2016.10.003","article-title":"Genetically re-engineered K562 cells significantly expand and functionally activate cord blood natural killer cells: potential for adoptive cellular immunotherapy","volume":"46","author":"Ayello","year":"2017","journal-title":"Exp. Hematol."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib11","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S1470-2045(19)30320-1","article-title":"IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial","volume":"20","author":"Bagot","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.mam.2020.100870_bib12","doi-asserted-by":"crossref","first-page":"101273","DOI":"10.1016\/j.smim.2019.04.001","article-title":"Hide and seek: plasticity of innate lymphoid cells in cancer","volume":"41","author":"Bald","year":"2019","journal-title":"Semin. Immunol."},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib13","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1002\/eji.201343448","article-title":"Hypoxia downregulates the expression of activating receptors involved in NK-cell-mediated target cell killing without affecting ADCC","volume":"43","author":"Balsamo","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"49","key":"10.1016\/j.mam.2020.100870_bib14","doi-asserted-by":"crossref","first-page":"20847","DOI":"10.1073\/pnas.0906481106","article-title":"Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity","volume":"106","author":"Balsamo","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2020.100870_bib15","doi-asserted-by":"crossref","first-page":"909","DOI":"10.3389\/fimmu.2019.00909","article-title":"The natural cytotoxicity receptors in health and disease","volume":"10","author":"Barrow","year":"2019","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41591-018-0085-8","article-title":"A\u00a0natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments","volume":"24","author":"Barry","year":"2018","journal-title":"Nat. Med."},{"issue":"5428","key":"10.1016\/j.mam.2020.100870_bib17","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.285.5428.727","article-title":"Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA","volume":"285","author":"Bauer","year":"1999","journal-title":"Science"},{"issue":"17","key":"10.1016\/j.mam.2020.100870_bib18","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1182\/blood-2013-03-489054","article-title":"Identification of a cellular ligand for the natural cytotoxicity receptor NKp44","volume":"122","author":"Baychelier","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100870_bib19","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fimmu.2019.01053","article-title":"The interaction between two worlds: MicroRNAs and toll-like receptors","volume":"10","author":"Bayraktar","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib20","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0166-6851(03)00160-9","article-title":"Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2","volume":"130","author":"Becker","year":"2003","journal-title":"Mol. Biochem. Parasitol."},{"issue":"45","key":"10.1016\/j.mam.2020.100870_bib21","doi-asserted-by":"crossref","first-page":"72961","DOI":"10.18632\/oncotarget.12150","article-title":"PD-1 mediates functional exhaustion of activated NK cells in patients with Kaposi sarcoma","volume":"7","author":"Beldi-Ferchiou","year":"2016","journal-title":"Oncotarget"},{"issue":"13","key":"10.1016\/j.mam.2020.100870_bib22","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1182\/blood-2010-02-271874","article-title":"The PD-1\/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody","volume":"116","author":"Benson","year":"2010","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib23","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1216291","article-title":"Zoledronic acid boosts gammadelta T-cell activity in children receiving alphabeta(+) T and CD19(+) cell-depleted grafts from an HLA-haplo-identical donor","volume":"6","author":"Bertaina","year":"2017","journal-title":"OncoImmunology"},{"key":"10.1016\/j.mam.2020.100870_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.3389\/fimmu.2015.00507","article-title":"Polyclonal expansion of NKG2C(+) NK cells in TAP-deficient patients","volume":"6","author":"Beziat","year":"2015","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib25","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1615\/CritRevImmunol.2019029559","article-title":"Biological and clinical significance of human NKRP1A\/LLT1 receptor\/ligand interactions","volume":"38","author":"Bialoszewska","year":"2018","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib26","first-page":"923135","article-title":"Polarization of ILC2s in peripheral blood might contribute to immunosuppressive microenvironment in patients with gastric cancer","volume":"2014","author":"Bie","year":"2014","journal-title":"J.\u00a0Immunol. Res."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/iji.12461","article-title":"Activating killer cell immunoglobulin-like receptors: detection, function and therapeutic use","volume":"47","author":"Blunt","year":"2020","journal-title":"Int. J. Immunogenet."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib28","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"Bottcher","year":"2018","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1084\/jem.194.3.235","article-title":"NTB-A [correction of GNTB-A], a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease","volume":"194","author":"Bottino","year":"2001","journal-title":"J.\u00a0Exp. Med."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib30","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.20090681","article-title":"The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans","volume":"206","author":"Brandt","year":"2009","journal-title":"J.\u00a0Exp. Med."},{"issue":"6669","key":"10.1016\/j.mam.2020.100870_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/35869","article-title":"HLA-E binds to natural killer cell receptors CD94\/NKG2A, B and C","volume":"391","author":"Braud","year":"1998","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/bjh.12090","article-title":"Anti-tumour immunotherapy with Vgamma9Vdelta2 T lymphocytes: from the bench to the bedside","volume":"160","author":"Braza","year":"2013","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.mam.2020.100870_bib33","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/QAD.0b013e3283328d1f","article-title":"Chronic HIV-1 viremia reverses NKG2A\/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection","volume":"24","author":"Brunetta","year":"2010","journal-title":"AIDS"},{"issue":"7293","key":"10.1016\/j.mam.2020.100870_bib35","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/nature08949","article-title":"Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology","volume":"464","author":"Buonocore","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1182\/blood-2007-09-077438","article-title":"Human natural killer cells","volume":"112","author":"Caligiuri","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100870_bib37","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.3389\/fimmu.2018.01031","article-title":"Tumor-targeting anti-CD20 antibodies mediate in\u00a0vitro expansion of memory natural killer cells: impact of CD16 affinity ligation conditions and in\u00a0vivo priming","volume":"9","author":"Capuano","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib38","first-page":"8795673","article-title":"Memory NK cell features exploitable in anticancer immunotherapy","volume":"2019","author":"Capuano","year":"2019","journal-title":"J.\u00a0Immunol. Res."},{"issue":"21","key":"10.1016\/j.mam.2020.100870_bib39","doi-asserted-by":"crossref","first-page":"5211","DOI":"10.1158\/1078-0432.CCR-16-1108","article-title":"Checkpoint inhibition of KIR2D with the monoclonal antibody IPH2101 induces contraction and hyporesponsiveness of NK cells in patients with myeloma","volume":"22","author":"Carlsten","year":"2016","journal-title":"Clin. Canc. Res."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib40","doi-asserted-by":"crossref","first-page":"6230","DOI":"10.4049\/jimmunol.1201895","article-title":"Human IL-2 mutein with higher antitumor efficacy than wild type IL-2","volume":"190","author":"Carmenate","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib41","doi-asserted-by":"crossref","first-page":"8280","DOI":"10.1038\/ncomms9280","article-title":"NCR(+)ILC3 concentrate in human lung cancer and associate with intratumoral lymphoid structures","volume":"6","author":"Carrega","year":"2015","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib42","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood.V99.3.754","article-title":"Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene","volume":"99","author":"Cartron","year":"2002","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib43","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1073\/pnas.0730640100","article-title":"Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells","volume":"100","author":"Castriconi","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib44","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.4049\/jimmunol.1202693","article-title":"Neuroblastoma-derived TGF-beta1 modulates the chemokine receptor repertoire of human resting NK cells","volume":"190","author":"Castriconi","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib45","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3389\/fimmu.2018.00847","article-title":"Interferon-Gamma at the crossroads of tumor immune surveillance or evasion","volume":"9","author":"Castro","year":"2018","journal-title":"Front. Immunol."},{"issue":"7230","key":"10.1016\/j.mam.2020.100870_bib46","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A\u00a0human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib47","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1182\/blood-2003-08-2820","article-title":"Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production","volume":"104","author":"Chalifour","year":"2004","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib48","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1158\/1078-0432.CCR-15-1631","article-title":"NKTR-214, an engineered cytokine with biased IL2 receptor binding, increased tumor exposure, and marked efficacy in mouse tumor models","volume":"22","author":"Charych","year":"2016","journal-title":"Clin. Canc. Res."},{"issue":"35","key":"10.1016\/j.mam.2020.100870_bib49","doi-asserted-by":"crossref","first-page":"56219","DOI":"10.18632\/oncotarget.11019","article-title":"Novel anti-CD3 chimeric antigen receptor targeting of aggressive T cell malignancies","volume":"7","author":"Chen","year":"2016","journal-title":"Oncotarget"},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib50","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1172\/JCI89717","article-title":"ILC2-modulated T cell-to-MDSC balance is associated with bladder cancer recurrence","volume":"127","author":"Chevalier","year":"2017","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mam.2020.100870_bib51","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.smim.2017.08.003","article-title":"Natural killer cell immunotherapies against cancer: checkpoint inhibitors and more","volume":"31","author":"Chiossone","year":"2017","journal-title":"Semin. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib52","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/leu.2013.279","article-title":"CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in\u00a0vitro and in\u00a0vivo antitumor activity against human multiple myeloma","volume":"28","author":"Chu","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib53","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/leu.2015.260","article-title":"CD56dimCD57+NKG2C+ NK cell expansion is associated with reduced leukemia relapse after reduced intensity HCT","volume":"30","author":"Cichocki","year":"2016","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.125553","article-title":"Adaptive NK cell reconstitution is associated with better clinical outcomes","volume":"4","author":"Cichocki","year":"2019","journal-title":"JCI Insight"},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib55","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1080\/21645515.2017.1321725","article-title":"Use of adjuvants for immunotherapy","volume":"13","author":"Circelli","year":"2017","journal-title":"Hum. Vaccines Immunother."},{"issue":"16","key":"10.1016\/j.mam.2020.100870_bib56","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2017-05-785659","article-title":"Phase 1 clinical trial using mbIL21 ex\u00a0vivo-expanded donor-derived NK cells after haploidentical transplantation","volume":"130","author":"Ciurea","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib57","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J.\u00a0Immunol."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib58","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-P","article-title":"The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma","volume":"79","author":"Coca","year":"1997","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.mam.2020.100870_bib59","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2010-05-283051","article-title":"Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia","volume":"116","author":"Cooley","year":"2010","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.mam.2020.100870_bib60","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"14","key":"10.1016\/j.mam.2020.100870_bib61","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1182\/blood-2016-08-734285","article-title":"Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs","volume":"129","author":"Corat","year":"2017","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib62","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","article-title":"Defective expression and function of natural killer cell-triggering receptors in patients with acute myeloid leukemia","volume":"99","author":"Costello","year":"2002","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib63","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1158\/1078-0432.CCR-15-1604","article-title":"Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients","volume":"22","author":"Curti","year":"2016","journal-title":"Clin. Canc. Res."},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib64","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1182\/blood-2008-07-144485","article-title":"The role of indoleamine 2,3-dioxygenase in the induction of immune tolerance: focus on hematology","volume":"113","author":"Curti","year":"2009","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib65","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1158\/2326-6066.CIR-13-0171","article-title":"Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade","volume":"2","author":"da Silva","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mam.2020.100870_bib66","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.coi.2018.03.013","article-title":"Next generation natural killer cells for cancer immunotherapy: the promise of genetic engineering","volume":"51","author":"Daher","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib67","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/j.bbmt.2015.05.025","volume":"21","author":"Davis","year":"2015","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib68","first-page":"486","article-title":"Natural killer cell adoptive transfer therapy: exploiting the first line of defense against cancer","volume":"21","author":"Davis","year":"2015","journal-title":"Canc. J."},{"issue":"23","key":"10.1016\/j.mam.2020.100870_bib69","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133103","article-title":"Discovery of specialized NK cell populations infiltrating human melanoma metastases","volume":"4","author":"de Andrade","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.mam.2020.100870_bib70","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3389\/fimmu.2018.01909","article-title":"Not all immune checkpoints are created equal","volume":"9","author":"De Sousa Linhares","year":"2018","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib71","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/cyto.b.21508","article-title":"Markers and function of human NK cells in normal and pathological conditions","volume":"92","author":"Del Zotto","year":"2017","journal-title":"Cytometry B Clin. Cytometry"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib72","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nm.2366","article-title":"Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors","volume":"17","author":"Delahaye","year":"2011","journal-title":"Nat. Med."},{"issue":"13","key":"10.1016\/j.mam.2020.100870_bib73","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1182\/blood-2006-03-006700","article-title":"The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function","volume":"108","author":"Della Chiesa","year":"2006","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib74","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1182\/blood-2011-08-372003","article-title":"Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus?","volume":"119","author":"Della Chiesa","year":"2012","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030264","article-title":"Membrane-bound IL-21 promotes sustained ex\u00a0vivo proliferation of human natural killer cells","volume":"7","author":"Denman","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mam.2020.100870_bib76","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coi.2018.02.004","article-title":"NKG2D and its ligands in cancer","volume":"51","author":"Dhar","year":"2018","journal-title":"Curr. Opin. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib77","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/imr.12518","article-title":"TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy","volume":"276","author":"Dougall","year":"2017","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib78","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1200\/JCO.1991.9.4.641","article-title":"A\u00a0phase II study of high-dose continuous infusion interleukin-2 with lymphokine-activated killer cells in patients with metastatic melanoma","volume":"9","author":"Dutcher","year":"1991","journal-title":"J.\u00a0Clin. Oncol."},{"issue":"6237","key":"10.1016\/j.mam.2020.100870_bib79","doi-asserted-by":"crossref","first-page":"aaa6566","DOI":"10.1126\/science.aaa6566","article-title":"Innate lymphoid cells. Innate lymphoid cells: a new paradigm in immunology","volume":"348","author":"Eberl","year":"2015","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib80","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s00109-011-0806-7","article-title":"Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging","volume":"90","author":"Eckl","year":"2012","journal-title":"J.\u00a0Mol. Med. (Berl.)"},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib81","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/ni.1947","article-title":"IL-12 initiates tumor rejection via lymphoid tissue-inducer cells bearing the natural cytotoxicity receptor NKp46","volume":"11","author":"Eisenring","year":"2010","journal-title":"Nat. Immunol."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib82","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.it.2011.06.001","article-title":"Unifying concepts of MHC-dependent natural killer cell education","volume":"32","author":"Elliott","year":"2011","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib83","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/j.1582-4934.2011.01343.x","article-title":"NK cells engineered to express a GD2 -specific antigen receptor display built-in ADCC-like activity against tumour cells of neuroectodermal origin","volume":"16","author":"Esser","year":"2012","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib84","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood-2009-09-245746","article-title":"Education of human natural killer cells by activating killer cell immunoglobulin-like receptors","volume":"115","author":"Fauriat","year":"2010","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib85","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1182\/blood-2005-03-1270","article-title":"Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients","volume":"106","author":"Fauriat","year":"2005","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib86","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1182\/bloodadvances.2018029371","article-title":"Novel CD19-targeted TriKE restores NK cell function and proliferative capacity in CLL","volume":"3","author":"Felices","year":"2019","journal-title":"Blood Adv."},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib87","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1182\/blood-2011-10-386995","article-title":"Cytomegalovirus reactivation after allogeneic transplantation promotes a lasting increase in educated NKG2C+ natural killer cells with potent function","volume":"119","author":"Foley","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib88","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.celrep.2016.05.095","article-title":"NKp80 defines a critical step during human natural killer cell development","volume":"16","author":"Freud","year":"2016","journal-title":"Cell Rep."},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib89","doi-asserted-by":"crossref","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-08-3712","article-title":"Expansion of highly cytotoxic human natural killer cells for cancer cell therapy","volume":"69","author":"Fujisaki","year":"2009","journal-title":"Canc. Res."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib90","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.4049\/jimmunol.1300379","article-title":"Critical role of p38 and GATA3 in natural helper cell function","volume":"191","author":"Furusawa","year":"2013","journal-title":"J.\u00a0Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib91","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib92","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib93","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1470730","article-title":"Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor","volume":"7","author":"Gaggero","year":"2018","journal-title":"OncoImmunology"},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib94","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ni.3800","article-title":"Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells","volume":"18","author":"Gao","year":"2017","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib95","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.cell.2019.04.041","article-title":"Multifunctional natural killer cell engagers targeting NKp46 trigger protective tumor immunity","volume":"177","author":"Gauthier","year":"2019","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib96","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1084\/jem.20051511","article-title":"CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J.\u00a0Exp. Med."},{"issue":"19","key":"10.1016\/j.mam.2020.100870_bib97","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1182\/blood-2013-10-533398","article-title":"CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets","volume":"123","author":"Gleason","year":"2014","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib98","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1158\/1535-7163.MCT-12-0692","article-title":"Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production","volume":"11","author":"Gleason","year":"2012","journal-title":"Mol. Canc. Therapeut."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib99","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1056\/NEJMsa1311707","article-title":"HLA match likelihoods for hematopoietic stem-cell grafts in the U.S. registry","volume":"371","author":"Gragert","year":"2014","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6908","key":"10.1016\/j.mam.2020.100870_bib100","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib101","article-title":"Prognostic significance of the dynamic change of programmed death-ligand 1 expression in patients with multiple myeloma","volume":"11","author":"Guan","year":"2019","journal-title":"Cureus"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib102","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2004-05-2058","article-title":"Imprint of human cytomegalovirus infection on the NK cell receptor repertoire","volume":"104","author":"Guma","year":"2004","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib103","doi-asserted-by":"crossref","first-page":"3624","DOI":"10.1182\/blood-2005-09-3682","article-title":"Expansion of CD94\/NKG2C+ NK cells in response to human cytomegalovirus-infected fibroblasts","volume":"107","author":"Guma","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib104","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/s41423-019-0224-2","article-title":"Targeting natural killer cells in solid tumors","volume":"16","author":"Habif","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/s41590-018-0082-6","article-title":"Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells","volume":"19","author":"Hammer","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib106","doi-asserted-by":"crossref","first-page":"11483","DOI":"10.1038\/srep11483","article-title":"CAR-engineered NK cells targeting wild-type EGFR and EGFRvIII enhance killing of glioblastoma and patient-derived glioblastoma stem cells","volume":"5","author":"Han","year":"2015","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib107","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.cyto.2011.09.028","article-title":"IL-15:IL-15 receptor alpha superagonist complex: high-level co-expression in recombinant mammalian cells, purification and characterization","volume":"56","author":"Han","year":"2011","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib108","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.175.3.1636","article-title":"TLR7\/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production","volume":"175","author":"Hart","year":"2005","journal-title":"J.\u00a0Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib109","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.4049\/jimmunol.1200796","article-title":"Comprehensive analysis of NKG2D ligand expression and release in leukemia: implications for NKG2D-mediated NK cell responses","volume":"189","author":"Hilpert","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fimmu.2012.00072","article-title":"Functional differences between human NKp44(-) and NKp44(+) RORC(+) innate lymphoid cells","volume":"3","author":"Hoorweg","year":"2012","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib111","first-page":"527","article-title":"Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review)","volume":"32","author":"Hoskin","year":"2008","journal-title":"Int. J. Oncol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib112","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.immuni.2012.06.020","article-title":"The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells","volume":"37","author":"Hoyler","year":"2012","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib113","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1172\/JCI99317","article-title":"Contribution of NK cells to immunotherapy mediated by PD-1\/PD-L1 blockade","volume":"128","author":"Hsu","year":"2018","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.mam.2020.100870_bib114","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1034\/j.1600-065X.2002.19004.x","article-title":"The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism","volume":"190","author":"Hsu","year":"2002","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.mam.2020.100870_bib115","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.3389\/fimmu.2019.01205","article-title":"Cancer immunotherapy based on natural killer cells: current progress and new opportunities","volume":"10","author":"Hu","year":"2019","journal-title":"Front. Immunol."},{"issue":"7534","key":"10.1016\/j.mam.2020.100870_bib116","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nature13848","article-title":"CEACAM1 regulates TIM-3-mediated tolerance and exhaustion","volume":"517","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib117","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/sj.leu.2403302","article-title":"Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia","volume":"18","author":"Imai","year":"2004","journal-title":"Leukemia"},{"issue":"9244","key":"10.1016\/j.mam.2020.100870_bib118","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/S0140-6736(00)03231-1","article-title":"Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence: an 11-year follow-up study of a general population","volume":"356","author":"Imai","year":"2000","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib119","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<577::AID-CNCR13>3.0.CO;2-V","article-title":"Prognostic value of intratumoral natural killer cells in gastric carcinoma","volume":"88","author":"Ishigami","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.mam.2020.100870_bib120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2407-13-59","article-title":"IL-22 is related to development of human colon cancer by activation of STAT3","volume":"13","author":"Jiang","year":"2013","journal-title":"BMC Canc."},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib121","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1101\/gr.137976.112","article-title":"Copy number variation leads to considerable diversity for B but not A haplotypes of the human KIR genes encoding NK cell receptors","volume":"22","author":"Jiang","year":"2012","journal-title":"Genome Res."},{"issue":"7143","key":"10.1016\/j.mam.2020.100870_bib122","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/nature05768","article-title":"Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands","volume":"447","author":"Kaiser","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib123","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.4049\/jimmunol.1500262","article-title":"Defective NK cells in acute myeloid leukemia patients at diagnosis are associated with blast transcriptional signatures of immune evasion","volume":"195","author":"Khaznadar","year":"2015","journal-title":"J.\u00a0Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib124","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.leu.2404080","article-title":"Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes","volume":"20","author":"Kiladjian","year":"2006","journal-title":"Leukemia"},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib125","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.4049\/jimmunol.1501730","article-title":"Intratumorally establishing type 2 innate lymphoid cells blocks tumor growth","volume":"196","author":"Kim","year":"2016","journal-title":"J.\u00a0Immunol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib126","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jaad.2009.12.052","article-title":"Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphoma","volume":"63","author":"Kim","year":"2010","journal-title":"J.\u00a0Am. Acad. Dermatol."},{"issue":"25","key":"10.1016\/j.mam.2020.100870_bib127","doi-asserted-by":"crossref","first-page":"10240","DOI":"10.1073\/pnas.1217158110","article-title":"Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells","volume":"110","author":"Klein Wolterink","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib128","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/hum.2018.247","article-title":"Preclinical assessment of suitable natural killer cell sources for chimeric antigen receptor natural killer-based \"Off-the-Shelf\" acute myeloid leukemia immunotherapies","volume":"30","author":"Kloess","year":"2019","journal-title":"Hum. Gene Ther."},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib129","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1002\/1097-0142(19941115)74:10<2850::AID-CNCR2820741018>3.0.CO;2-T","article-title":"Cardiotoxicity as a dose-limiting factor in a schedule of high dose bolus therapy with interleukin-2 and alpha-interferon. An unexpectedly frequent complication","volume":"74","author":"Kruit","year":"1994","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib130","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1182\/blood-2008-05-157354","article-title":"Human NK cells can control CMV infection in the absence of T cells","volume":"112","author":"Kuijpers","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.mam.2020.100870_bib131","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fimmu.2019.00879","article-title":"Expansion of human NK cells using K562 cells expressing OX40 ligand and short exposure to IL-21","volume":"10","author":"Kweon","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib132","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"6668","key":"10.1016\/j.mam.2020.100870_bib133","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/35642","article-title":"Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells","volume":"391","author":"Lanier","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib134","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.immuni.2015.02.013","article-title":"Epigenetic modification and antibody-dependent expansion of memory-like NK cells in human cytomegalovirus-infected individuals","volume":"42","author":"Lee","year":"2015","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib135","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"13","key":"10.1016\/j.mam.2020.100870_bib136","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1158\/1078-0432.CCR-13-1766","article-title":"Infusions of allogeneic natural killer cells as cancer therapy","volume":"20","author":"Leung","year":"2014","journal-title":"Clin. Canc. Res."},{"issue":"15","key":"10.1016\/j.mam.2020.100870_bib137","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.18632\/oncotarget.3453","article-title":"Characterization of tumor infiltrating natural killer cell subset","volume":"6","author":"Levi","year":"2015","journal-title":"Oncotarget"},{"issue":"7395","key":"10.1016\/j.mam.2020.100870_bib138","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10975","article-title":"Exploiting a natural conformational switch to engineer an interleukin-2 'superkine'","volume":"484","author":"Levin","year":"2012","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib139","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1016\/j.bbmt.2016.08.006","article-title":"Selective depletion of alphabeta T cells and B cells for human leukocyte antigen-haploidentical hematopoietic stem cell transplantation. A three-year follow-up of procedure efficiency","volume":"22","author":"Li Pira","year":"2016","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib140","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.canlet.2011.12.020","article-title":"Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and Ido","volume":"318","author":"Li","year":"2012","journal-title":"Canc. Lett."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib141","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12032-013-0663-z","article-title":"Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity","volume":"30","author":"Li","year":"2013","journal-title":"Med. Oncol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib142","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-transduced natural killer cells in CD19-positive lymphoid tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib143","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/leu.2017.226","article-title":"Cord blood NK cells engineered to express IL-15 and a CD19-targeted CAR show long-term persistence and potent antitumor activity","volume":"32","author":"Liu","year":"2018","journal-title":"Leukemia"},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib144","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1158\/2326-6066.CIR-16-0296","article-title":"Ex\u00a0vivo expanded adaptive NK cells effectively kill primary acute lymphoblastic leukemia cells","volume":"5","author":"Liu","year":"2017","journal-title":"Cancer Immunol. Res."},{"issue":"44","key":"10.1016\/j.mam.2020.100870_bib145","doi-asserted-by":"crossref","first-page":"6143","DOI":"10.1038\/onc.2017.209","article-title":"Increased expression of programmed cell death protein 1 on NK cells inhibits NK-cell-mediated anti-tumor function and indicates poor prognosis in digestive cancers","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib146","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1182\/blood-2017-04-779769","article-title":"Outcome of children with acute leukemia given HLA-haploidentical HSCT after alphabeta T-cell and B-cell depletion","volume":"130","author":"Locatelli","year":"2017","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib147","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.it.2018.04.009","article-title":"NK cells mediate a crucial graft-versus-leukemia effect in haploidentical-HSCT to cure high-risk acute leukemia","volume":"39","author":"Locatelli","year":"2018","journal-title":"Trends Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib148","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-065X.2008.00660.x","article-title":"Negative signaling by inhibitory receptors: the NK cell paradigm","volume":"224","author":"Long","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.mam.2020.100870_bib149","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3389\/fimmu.2013.00499","article-title":"Signatures of human NK cell development and terminal differentiation","volume":"4","author":"Luetke-Eversloh","year":"2013","journal-title":"Front. Immunol."},{"issue":"21","key":"10.1016\/j.mam.2020.100870_bib150","doi-asserted-by":"crossref","first-page":"6621","DOI":"10.1158\/0008-5472.CAN-11-0792","article-title":"Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition","volume":"71","author":"Mamessier","year":"2011","journal-title":"Canc. Res."},{"issue":"20","key":"10.1016\/j.mam.2020.100870_bib151","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1182\/blood-2014-09-599993","article-title":"Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality","volume":"125","author":"Mancusi","year":"2015","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib152","doi-asserted-by":"crossref","first-page":"3367","DOI":"10.1002\/eji.200324425","article-title":"CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity","volume":"33","author":"Marcenaro","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib153","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4419-5632-3_5","article-title":"Bridging innate NK cell functions with adaptive immunity","volume":"780","author":"Marcenaro","year":"2011","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib154","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1093\/intimm\/dxn073","article-title":"Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC","volume":"20","author":"Marcenaro","year":"2008","journal-title":"Int. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib155","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fimmu.2019.00910","article-title":"Innate lymphoid cells: expression of PD-1 and other checkpoints in normal and pathological conditions","volume":"10","author":"Mariotti","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib156","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S0198-8859(03)00067-3","article-title":"Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002","volume":"64","author":"Marsh","year":"2003","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib157","doi-asserted-by":"crossref","first-page":"6280","DOI":"10.1038\/ncomms7280","article-title":"Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in\u00a0vivo","volume":"6","author":"Matsumoto","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib158","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1056\/NEJMoa1709866","article-title":"Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia","volume":"378","author":"Maude","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib159","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S1074-7613(00)80371-4","article-title":"Developing lymph nodes collect CD4+CD3- LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells","volume":"7","author":"Mebius","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2020.100870_bib160","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2018.00283","article-title":"Chimeric antigen receptor expressing natural killer cells for the immunotherapy of cancer","volume":"9","author":"Mehta","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib161","doi-asserted-by":"crossref","first-page":"3038","DOI":"10.3389\/fimmu.2019.03038","article-title":"Influence of the tumor microenvironment on NK cell function in solid tumors","volume":"10","author":"Melaiu","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib162","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1158\/0008-5472.CAN-13-1303","article-title":"Mature cytotoxic CD56(bright)\/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma","volume":"74","author":"Messaoudene","year":"2014","journal-title":"Canc. Res."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib163","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1182\/blood-2004-07-2974","article-title":"Successful adoptive transfer and in\u00a0vivo expansion of human haploidentical NK cells in patients with cancer","volume":"105","author":"Miller","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib164","first-page":"34","article-title":"Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in\u00a0vivo natural killer cell activity","volume":"3","author":"Miller","year":"1997","journal-title":"Biol. Blood Marrow Transplant."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib165","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/eji.1830270612","article-title":"Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94\/NKG2-A as the only HLA class I-specific inhibitory receptor","volume":"27","author":"Mingari","year":"1997","journal-title":"Eur. J. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib166","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2012.08.015","article-title":"The transcription factor GATA3 is essential for the function of human type 2 innate lymphoid cells","volume":"37","author":"Mjosberg","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.mam.2020.100870_bib167","first-page":"646","article-title":"Unique Eomes(+) NK cell subsets are present in uterus and decidua during early pregnancy","volume":"6","author":"Montaldo","year":"2015","journal-title":"Front. Immunol."},{"issue":"17","key":"10.1016\/j.mam.2020.100870_bib168","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1182\/blood-2011-09-379693","article-title":"Human NK cells at early stages of differentiation produce CXCL8 and express CD161 molecule that functions as an activating receptor","volume":"119","author":"Montaldo","year":"2012","journal-title":"Blood"},{"issue":"34","key":"10.1016\/j.mam.2020.100870_bib169","doi-asserted-by":"crossref","first-page":"10762","DOI":"10.1073\/pnas.1509070112","article-title":"IL-33 promotes an innate immune pathway of intestinal tissue protection dependent on amphiregulin-EGFR interactions","volume":"112","author":"Monticelli","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib170","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/ni.2131","article-title":"Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus","volume":"12","author":"Monticelli","year":"2011","journal-title":"Nat. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib171","doi-asserted-by":"crossref","first-page":"546","DOI":"10.4161\/mabs.3.6.18123","article-title":"A\u00a0novel bispecific antibody format enables simultaneous bivalent and monovalent co-engagement of distinct target antigens","volume":"3","author":"Moore","year":"2011","journal-title":"mAbs"},{"key":"10.1016\/j.mam.2020.100870_bib172","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","article-title":"Receptors for HLA class-I molecules in human natural killer cells","volume":"14","author":"Moretta","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib173","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.19.1.197","article-title":"Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis","volume":"19","author":"Moretta","year":"2001","journal-title":"Annu. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib174","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.182.3.875","article-title":"Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells","volume":"182","author":"Moretta","year":"1995","journal-title":"J.\u00a0Exp. Med."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib175","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/eji.201546079","article-title":"The generation of human innate lymphoid cells is influenced by the source of hematopoietic stem cells and by the use of G-CSF","volume":"46","author":"Moretta","year":"2016","journal-title":"Eur. J. Immunol."},{"issue":"19","key":"10.1016\/j.mam.2020.100870_bib176","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1182\/blood-2010-09-303057","article-title":"Dissecting CD56dim human NK cells","volume":"116","author":"Moretta","year":"2010","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib177","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.febslet.2011.04.061","article-title":"Human NK receptors: from the molecules to the therapy of high risk leukemias","volume":"585","author":"Moretta","year":"2011","journal-title":"FEBS Lett."},{"issue":"7280","key":"10.1016\/j.mam.2020.100870_bib178","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nature08636","article-title":"Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells","volume":"463","author":"Moro","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib179","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3324\/haematol.2015.134155","article-title":"Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing alphabeta+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies","volume":"101","author":"Muccio","year":"2016","journal-title":"Haematologica"},{"key":"10.1016\/j.mam.2020.100870_bib180","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3389\/fimmu.2018.01050","article-title":"Late development of FcepsilonRgamma(neg) adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients","volume":"9","author":"Muccio","year":"2018","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib181","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s00262-007-0383-3","article-title":"Expression of a CD20-specific chimeric antigen receptor enhances cytotoxic activity of NK cells and overcomes NK-resistance of lymphoma and leukemia cells","volume":"57","author":"Muller","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib182","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2013-11-536888","article-title":"Activated innate lymphoid cells are associated with a reduced susceptibility to graft-versus-host disease","volume":"124","author":"Munneke","year":"2014","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib183","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aam9628","article-title":"Complement factor P is a ligand for the natural killer cell-activating receptor NKp46","volume":"2","author":"Narni-Mancinelli","year":"2017","journal-title":"Sci. Immunol."},{"issue":"26","key":"10.1016\/j.mam.2020.100870_bib184","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"7293","key":"10.1016\/j.mam.2020.100870_bib185","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/nature08900","article-title":"Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity","volume":"464","author":"Neill","year":"2010","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib186","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/s41590-019-0448-4","article-title":"A\u00a0subset of HLA-DP molecules serve as ligands for the natural cytotoxicity receptor NKp44","volume":"20","author":"Niehrs","year":"2019","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib187","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/icb.2017.6","article-title":"Antibody-dependent cell cytotoxicity: immunotherapy strategies enhancing effector NK cells","volume":"95","author":"Ochoa","year":"2017","journal-title":"Immunol. Cell Biol."},{"issue":"17","key":"10.1016\/j.mam.2020.100870_bib188","doi-asserted-by":"crossref","first-page":"2744","DOI":"10.1182\/blood-2014-03-565069","article-title":"KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL","volume":"124","author":"Oevermann","year":"2014","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.mam.2020.100870_bib189","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-17-1032","article-title":"Restoration of natural killer cell antimetastatic activity by IL12 and checkpoint blockade","volume":"77","author":"Ohs","year":"2017","journal-title":"Canc. Res."},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib190","doi-asserted-by":"crossref","first-page":"5083","DOI":"10.4049\/jimmunol.158.11.5083","article-title":"Human killer cell activatory receptors for MHC class I molecules are included in a multimeric complex expressed by natural killer cells","volume":"158","author":"Olcese","year":"1997","journal-title":"J.\u00a0Immunol."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib191","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri1570","article-title":"MHC class I molecules and KIRs in human history, health and survival","volume":"5","author":"Parham","year":"2005","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib192","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-term follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib193","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1052353","article-title":"Natural Killer (NK)\/melanoma cell interaction induces NK-mediated release of chemotactic High Mobility Group Box-1 (HMGB1) capable of amplifying NK cell recruitment","volume":"4","author":"Parodi","year":"2015","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib194","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1084\/jem.192.3.337","article-title":"X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells","volume":"192","author":"Parolini","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"issue":"16","key":"10.1016\/j.mam.2020.100870_bib195","doi-asserted-by":"crossref","first-page":"14360","DOI":"10.18632\/oncotarget.3965","article-title":"Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer","volume":"6","author":"Pasero","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.mam.2020.100870_bib196","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.3389\/fimmu.2019.01179","article-title":"Killer Ig-like receptors (KIRs): their role in NK cell modulation and developments leading to their clinical exploitation","volume":"10","author":"Pende","year":"2019","journal-title":"Front. Immunol."},{"issue":"13","key":"10.1016\/j.mam.2020.100870_bib197","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib198","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1084\/jem.190.10.1505","article-title":"Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells","volume":"190","author":"Pende","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.mam.2020.100870_bib199","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.3389\/fimmu.2019.01242","article-title":"PD\/1-PD-Ls checkpoint: insight on the potential role of NK cells","volume":"10","author":"Pesce","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib200","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jaci.2016.04.025","article-title":"Identification of a subset of human natural killer cells expressing high levels of programmed death 1: a phenotypic and functional characterization","volume":"139","author":"Pesce","year":"2017","journal-title":"J.\u00a0Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib201","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.1001224","article-title":"B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape","volume":"4","author":"Pesce","year":"2015","journal-title":"OncoImmunology"},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib202","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1084\/jem.188.5.953","article-title":"Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity","volume":"188","author":"Pessino","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib203","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1182\/blood.V88.6.2279.bloodjournal8862279","article-title":"CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis","volume":"88","author":"Pierson","year":"1996","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib204","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1158\/0008-5472.CAN-11-2544","article-title":"Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity","volume":"72","author":"Pietra","year":"2012","journal-title":"Canc. Res."},{"issue":"13","key":"10.1016\/j.mam.2020.100870_bib205","doi-asserted-by":"crossref","first-page":"4157","DOI":"10.1182\/blood-2004-05-1860","article-title":"p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells","volume":"104","author":"Pisegna","year":"2004","journal-title":"Blood"},{"issue":"16","key":"10.1016\/j.mam.2020.100870_bib206","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1158\/0008-5472.CAN-10-4179","article-title":"Profound coordinated alterations of intratumoral NK cell phenotype and function in lung carcinoma","volume":"71","author":"Platonova","year":"2011","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib207","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.immuni.2007.10.010","article-title":"Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells","volume":"27","author":"Pogge von Strandmann","year":"2007","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib208","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1073\/pnas.90.10.4465","article-title":"Extrathymic differentiation of T lymphocytes and natural killer cells from human embryonic liver precursors","volume":"90","author":"Poggi","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"25","key":"10.1016\/j.mam.2020.100870_bib209","doi-asserted-by":"crossref","first-page":"11489","DOI":"10.1073\/pnas.1003988107","article-title":"Systemically dispersed innate IL-13-expressing cells in type 2 immunity","volume":"107","author":"Price","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mam.2020.100870_bib210","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fimmu.2017.01317","article-title":"Elusive role of the CD94\/NKG2C NK cell receptor in the response to cytomegalovirus: novel experimental observations in a reporter cell system","volume":"8","author":"Pupuleku","year":"2017","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib211","doi-asserted-by":"crossref","first-page":"e15115","DOI":"10.1371\/journal.pone.0015115","article-title":"Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus","volume":"5","author":"Pyo","year":"2010","journal-title":"PloS One"},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib212","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1038\/s41375-019-0613-7","article-title":"Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B Cell Precursor Acute Lymphoblastic Leukemia","volume":"34","author":"Quintarelli","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.mam.2020.100870_bib213","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib214","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4049\/jimmunol.1601236","article-title":"Adaptive NKG2C+ NK cell response and the risk of cytomegalovirus infection in kidney transplant recipients","volume":"198","author":"Redondo-Pachon","year":"2017","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib215","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fimmu.2017.00868","article-title":"TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells","volume":"8","author":"Regis","year":"2017","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.mam.2020.100870_bib216","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2013-01-476606","article-title":"Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity","volume":"121","author":"Reiners","year":"2013","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.mam.2020.100870_bib217","doi-asserted-by":"crossref","first-page":"6006","DOI":"10.1182\/blood-2011-07-338822","article-title":"Haploidentical hematopoietic transplantation: current status and future perspectives","volume":"118","author":"Reisner","year":"2011","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib218","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/17474086.2017.1396890","article-title":"Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia","volume":"10","author":"Ribera","year":"2017","journal-title":"Expet Rev. Hematol."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib219","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705963","article-title":"Searching for alternative hematopoietic stem cell donors for pediatric patients","volume":"41","author":"Rocha","year":"2007","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib220","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.it.2016.01.005","article-title":"Immune adaptation to environmental influence: the case of NK cells and HCMV","volume":"37","author":"Rolle","year":"2016","journal-title":"Trends Immunol."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib221","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.celrep.2018.07.069","article-title":"Distinct HLA-E peptide complexes modify antibody-driven effector functions of adaptive NK cells","volume":"24","author":"Rolle","year":"2018","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib222","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1111\/jcmm.12810","article-title":"CD19-CAR engineered NK-92 cells are sufficient to overcome NK cell resistance in B-cell malignancies","volume":"20","author":"Romanski","year":"2016","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"23","key":"10.1016\/j.mam.2020.100870_bib223","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1182\/blood-2017-12-823757","article-title":"First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation","volume":"131","author":"Romee","year":"2018","journal-title":"Blood"},{"issue":"357","key":"10.1016\/j.mam.2020.100870_bib224","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2341","article-title":"Cytokine-induced memory-like natural killer cells exhibit enhanced responses against myeloid leukemia","volume":"8","author":"Romee","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"15","key":"10.1016\/j.mam.2020.100870_bib225","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1056\/NEJM198704093161501","article-title":"A\u00a0progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone","volume":"316","author":"Rosenberg","year":"1987","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib226","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.161.5.1169","article-title":"Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2","volume":"161","author":"Rosenberg","year":"1985","journal-title":"J.\u00a0Exp. Med."},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib227","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.1102267","article-title":"Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44","volume":"187","author":"Rosental","year":"2011","journal-title":"J.\u00a0Immunol."},{"issue":"5562","key":"10.1016\/j.mam.2020.100870_bib228","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib229","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1182\/blood-2006-07-038687","article-title":"Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value","volume":"110","author":"Ruggeri","year":"2007","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib230","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1158\/0008-5472.CAN-13-0371","article-title":"Immune infiltrates are prognostic factors in localized gastrointestinal stromal tumors","volume":"73","author":"Rusakiewicz","year":"2013","journal-title":"Canc. Res."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib231","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1182\/blood-2017-05-780668","article-title":"NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications","volume":"131","author":"Russo","year":"2018","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib232","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.4049\/jimmunol.1701030","article-title":"TIM-3 engagement promotes effector memory T cell differentiation of human antigen-specific CD8 T cells by activating mTORC1","volume":"199","author":"Sabins","year":"2017","journal-title":"J.\u00a0Immunol."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib233","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.4049\/jimmunol.169.8.4098","article-title":"Cutting edge: down-regulation of MICA on human tumors by proteolytic shedding","volume":"169","author":"Salih","year":"2002","journal-title":"J.\u00a0Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib234","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1186\/s12885-018-4262-4","article-title":"Activated innate lymphoid cell populations accumulate in human tumour tissues","volume":"18","author":"Salimi","year":"2018","journal-title":"BMC Canc."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib235","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/ni.1684","article-title":"RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells","volume":"10","author":"Sanos","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.mam.2020.100870_bib236","doi-asserted-by":"crossref","first-page":"30555","DOI":"10.1038\/srep30555","article-title":"Discovery of a metastatic immune escape mechanism initiated by the loss of expression of the tumour biomarker interleukin-33","volume":"6","author":"Saranchova","year":"2016","journal-title":"Sci. Rep."},{"issue":"19","key":"10.1016\/j.mam.2020.100870_bib237","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1158\/0008-5472.CAN-16-0839","article-title":"Adaptive NK cells with low TIGIT expression are inherently resistant to myeloid-derived suppressor cells","volume":"76","author":"Sarhan","year":"2016","journal-title":"Canc. Res."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib238","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1158\/2326-6066.CIR-17-0498","article-title":"Adaptive NK cells resist regulatory T-cell suppression driven by IL37","volume":"6","author":"Sarhan","year":"2018","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.mam.2020.100870_bib239","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fimmu.2017.00329","article-title":"Umbilical cord blood natural killer cells, their characteristics, and potential clinical applications","volume":"8","author":"Sarvaria","year":"2017","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.immuni.2008.11.001","article-title":"Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense","volume":"29","author":"Satoh-Takayama","year":"2008","journal-title":"Immunity"},{"issue":"13","key":"10.1016\/j.mam.2020.100870_bib241","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1158\/0008-5472.CAN-13-3017","article-title":"Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30","volume":"74","author":"Schlecker","year":"2014","journal-title":"Canc. Res."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib242","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ijc.11321","article-title":"Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes","volume":"106","author":"Schleypen","year":"2003","journal-title":"Int. J. Canc."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib243","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"issue":"14","key":"10.1016\/j.mam.2020.100870_bib244","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1182\/blood-2016-08-734236","article-title":"Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells","volume":"129","author":"Schlums","year":"2017","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib245","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4049\/jimmunol.172.1.138","article-title":"APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA","volume":"172","author":"Schmidt","year":"2004","journal-title":"J.\u00a0Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib246","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.4143\/crt.2016.491","article-title":"Engineering of anti-CD133 trispecific molecule capable of inducing NK expansion and driving antibody-dependent cell-mediated cytotoxicity","volume":"49","author":"Schmohl","year":"2017","journal-title":"Canc. Res. Treat."},{"issue":"45","key":"10.1016\/j.mam.2020.100870_bib247","doi-asserted-by":"crossref","first-page":"73830","DOI":"10.18632\/oncotarget.12073","article-title":"Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker","volume":"7","author":"Schmohl","year":"2016","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.mam.2020.100870_bib248","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1182\/blood-2018-03-838474","article-title":"Human AML activates the aryl hydrocarbon receptor pathway to impair NK cell development and function","volume":"132","author":"Scoville","year":"2018","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib249","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1074-7613(00)70060-4","article-title":"DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes","volume":"4","author":"Shibuya","year":"1996","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib250","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1158\/2326-6066.CIR-15-0195","article-title":"IL2 variant circumvents ICOS+ regulatory T-cell expansion and promotes NK cell activation","volume":"4","author":"Sim","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib251","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.immuni.2016.11.005","article-title":"Human innate lymphoid cell subsets possess tissue-type based heterogeneity in phenotype and frequency","volume":"46","author":"Simoni","year":"2017","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib252","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1002\/eji.200535781","article-title":"Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells","volume":"36","author":"Sivori","year":"2006","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib253","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/intimm\/dxm105","article-title":"Heterogeneity of TLR3 mRNA transcripts and responsiveness to poly (I:C) in human NK cells derived from different donors","volume":"19","author":"Sivori","year":"2007","journal-title":"Int. Immunol."},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib254","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1182\/blood-2009-12-256586","article-title":"A\u00a0novel KIR-associated function: evidence that CpG DNA uptake and shuttling to early endosomes is mediated by KIR3DL2","volume":"116","author":"Sivori","year":"2010","journal-title":"Blood"},{"issue":"27","key":"10.1016\/j.mam.2020.100870_bib255","doi-asserted-by":"crossref","first-page":"10116","DOI":"10.1073\/pnas.0403744101","article-title":"CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells","volume":"101","author":"Sivori","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib256","doi-asserted-by":"crossref","first-page":"4526","DOI":"10.1073\/pnas.072065999","article-title":"Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in\u00a0vitro differentiation","volume":"99","author":"Sivori","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib257","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.it.2010.05.007","article-title":"Extending killer Ig-like receptor function: from HLA class I recognition to sensors of microbial products","volume":"31","author":"Sivori","year":"2010","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib258","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.3390\/jcm8101702","article-title":"NK cell-based immunotherapy for hematological malignancies","volume":"8","author":"Sivori","year":"2019","journal-title":"J.\u00a0Clin. Med."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib259","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I","article-title":"2B4 functions as a co-receptor in human NK cell activation","volume":"30","author":"Sivori","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib260","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1002\/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1","article-title":"NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells","volume":"29","author":"Sivori","year":"1999","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib261","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41423-019-0206-4","article-title":"Human NK cells: surface receptors, inhibitory checkpoints, and translational applications","volume":"16","author":"Sivori","year":"2019","journal-title":"Cell. Mol. Immunol."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib262","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.186.7.1129","article-title":"p46, a novel natural killer cell-specific surface molecule that mediates cell activation","volume":"186","author":"Sivori","year":"1997","journal-title":"J.\u00a0Exp. Med."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib263","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/nri3365","article-title":"Innate lymphoid cells--a proposal for uniform nomenclature","volume":"13","author":"Spits","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib264","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/ni.3482","article-title":"NK cells and type 1 innate lymphoid cells: partners in host defense","volume":"17","author":"Spits","year":"2016","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib265","doi-asserted-by":"crossref","first-page":"836","DOI":"10.3324\/haematol.2013.087536","article-title":"Leukemia-induced phenotypic and functional defects in natural killer cells predict failure to achieve remission in acute myeloid leukemia","volume":"99","author":"Stringaris","year":"2014","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib266","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hep.30347","article-title":"Human CD96 correlates to natural killer cell exhaustion and predicts the prognosis of human hepatocellular carcinoma","volume":"70","author":"Sun","year":"2019","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib267","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.4049\/jimmunol.1003035","article-title":"NK cells and immune \"memory\"","volume":"186","author":"Sun","year":"2011","journal-title":"J.\u00a0Immunol."},{"issue":"8","key":"10.1016\/j.mam.2020.100870_bib268","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3109\/14653249.2010.504770","article-title":"Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor","volume":"12","author":"Sutlu","year":"2010","journal-title":"Cytotherapy"},{"issue":"9","key":"10.1016\/j.mam.2020.100870_bib269","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.3324\/haematol.2010.039743","article-title":"Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor-beta1","volume":"96","author":"Szczepanski","year":"2011","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib270","first-page":"1083","article-title":"First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemia","volume":"8","author":"Tang","year":"2018","journal-title":"Am. J. Canc. Res."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib271","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/cgt.2011.66","article-title":"Retargeting NK92 cells using an HLA-A2-restricted, EBNA3C-specific chimeric antigen receptor","volume":"19","author":"Tassev","year":"2012","journal-title":"Canc. Gene Ther."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib272","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1084\/jem.20161653","article-title":"PD-1 regulates KLRG1(+) group 2 innate lymphoid cells","volume":"214","author":"Taylor","year":"2017","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.mam.2020.100870_bib273","doi-asserted-by":"crossref","first-page":"737","DOI":"10.3389\/fimmu.2018.00737","article-title":"Implication of interleukin-12\/15\/18 and ruxolitinib in the phenotype, proliferation, and polyfunctionality of human cytokine-preactivated natural killer cells","volume":"9","author":"Terren","year":"2018","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib274","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.jcyt.2013.06.017","article-title":"Treatment of patients with advanced cancer with the natural killer cell line NK-92","volume":"15","author":"Tonn","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.mam.2020.100870_bib275","doi-asserted-by":"crossref","first-page":"101276","DOI":"10.1016\/j.smim.2019.04.004","article-title":"The pro- and anti-tumor role of ILC2s","volume":"41","author":"Trabanelli","year":"2019","journal-title":"Semin. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib276","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41467-017-00678-2","article-title":"Tumour-derived PGD2 and NKp30-B7H6 engagement drives an immunosuppressive ILC2-MDSC axis","volume":"8","author":"Trabanelli","year":"2017","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib277","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1084\/jem.171.5.1393","article-title":"LAG-3, a novel lymphocyte activation gene closely related to CD4","volume":"171","author":"Triebel","year":"1990","journal-title":"J.\u00a0Exp. Med."},{"issue":"3","key":"10.1016\/j.mam.2020.100870_bib278","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/s41375-019-0585-7","article-title":"PMN-MDSC are a new target to rescue graft-versus-leukemia activity of NK cells in haplo-HSC transplantation","volume":"34","author":"Tumino","year":"2019","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib279","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1002\/ijc.32262","article-title":"Presence of innate lymphoid cells in pleural effusions of primary and metastatic tumors: functional analysis and expression of PD-1 receptor","volume":"145","author":"Tumino","year":"2019","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.mam.2020.100870_bib280","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.3389\/fimmu.2019.03140","article-title":"Helper innate lymphoid cells in human tumors: a double-edged sword?","volume":"10","author":"Tumino","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib281","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1182\/blood.V100.4.1265.h81602001265_1265_1273","article-title":"Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction","volume":"100","author":"Uherek","year":"2002","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib282","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1074-7613(00)80394-5","article-title":"Human diversity in killer cell inhibitory receptor genes","volume":"7","author":"Uhrberg","year":"1997","journal-title":"Immunity"},{"issue":"10","key":"10.1016\/j.mam.2020.100870_bib283","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.4049\/jimmunol.164.10.5019","article-title":"Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis","volume":"164","author":"Ulbrecht","year":"2000","journal-title":"J.\u00a0Immunol."},{"issue":"14","key":"10.1016\/j.mam.2020.100870_bib284","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1158\/1078-0432.CCR-15-2710","article-title":"IL15 trispecific killer engagers (TriKE) make natural killer cells specific to CD33+ targets while also inducing persistence, in\u00a0vivo expansion, and enhanced function","volume":"22","author":"Vallera","year":"2016","journal-title":"Clin. Canc. Res."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nri3384","article-title":"Six-of-the-best: unique contributions of gammadelta T cells to immunology","volume":"13","author":"Vantourout","year":"2013","journal-title":"Nat. Rev. Immunol."},{"issue":"16","key":"10.1016\/j.mam.2020.100870_bib286","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1182\/blood-2017-07-796342","article-title":"Immune evasion via PD-1\/PD-L1 on NK cells and monocyte\/macrophages is more prominent in Hodgkin lymphoma than DLBCL","volume":"131","author":"Vari","year":"2018","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.mam.2020.100870_bib287","doi-asserted-by":"crossref","first-page":"17675","DOI":"10.18632\/oncotarget.24832","article-title":"A\u00a0phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies","volume":"9","author":"Vey","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.mam.2020.100870_bib288","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1146\/annurev.immunol.20.092501.134942","article-title":"KIR: diverse, rapidly evolving receptors of innate and adaptive immunity","volume":"20","author":"Vilches","year":"2002","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib289","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(01)00292-6","article-title":"Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer","volume":"35","author":"Villegas","year":"2002","journal-title":"Lung Canc."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib290","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.3324\/haematol.2014.110494","article-title":"IL-1beta-releasing human acute myeloid leukemia blasts modulate natural killer cell differentiation from CD34+ precursors","volume":"100","author":"Vitale","year":"2015","journal-title":"Haematologica"},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib291","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1084\/jem.187.12.2065","article-title":"NKp44, a novel triggering surface molecule specifically expressed by activated natural killer cells, is involved in non-major histocompatibility complex-restricted tumor cell lysis","volume":"187","author":"Vitale","year":"1998","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.mam.2020.100870_bib292","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.3389\/fimmu.2019.01415","article-title":"An historical overview: the discovery of how NK cells can kill enemies, recruit defense troops, and more","volume":"10","author":"Vitale","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib293","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/1521-4141(200101)31:1<233::AID-IMMU233>3.0.CO;2-4","article-title":"Identification of NKp80, a novel triggering molecule expressed by human NK cells","volume":"31","author":"Vitale","year":"2001","journal-title":"Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib294","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.cell.2018.07.017","article-title":"Innate lymphoid cells: 10 Years on","volume":"174","author":"Vivier","year":"2018","journal-title":"Cell"},{"issue":"6013","key":"10.1016\/j.mam.2020.100870_bib295","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1126\/science.1198687","article-title":"Innate or adaptive immunity? The example of natural killer cells","volume":"331","author":"Vivier","year":"2011","journal-title":"Science"},{"issue":"36","key":"10.1016\/j.mam.2020.100870_bib296","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1200\/JCO.2016.67.3301","article-title":"Phase I\/phase II study of blinatumomab in pediatric patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"34","author":"von Stackelberg","year":"2016","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.mam.2020.100870_bib297","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3389\/fimmu.2017.00676","article-title":"A\u00a0two-phase expansion protocol combining interleukin (IL)-15 and IL-21 improves natural killer cell proliferation and cytotoxicity against rhabdomyosarcoma","volume":"8","author":"Wagner","year":"2017","journal-title":"Front. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.mam.2020.100870_bib298","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cell.2018.11.010","article-title":"Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3","volume":"176","author":"Wang","year":"2019","journal-title":"Cell"},{"issue":"4 Suppl.\u00a092","key":"10.1016\/j.mam.2020.100870_bib299","first-page":"S87","article-title":"The IL-23 to IL-17 cascade inflammation-related cancers","volume":"33","author":"Wang","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.mam.2020.100870_bib300","doi-asserted-by":"crossref","first-page":"578","DOI":"10.3109\/08820139.2015.1052145","article-title":"The clinical significance of abnormal Tim-3 expression on NK cells from patients with gastric cancer","volume":"44","author":"Wang","year":"2015","journal-title":"Immunol. Invest."},{"issue":"14","key":"10.1016\/j.mam.2020.100870_bib301","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1158\/1078-0432.CCR-13-0505","article-title":"Targeting natural killer cells to acute myeloid leukemia in\u00a0vitro with a CD16 x 33 bispecific killer cell engager and ADAM17 inhibition","volume":"19","author":"Wiernik","year":"2013","journal-title":"Clin. Canc. Res."},{"issue":"11","key":"10.1016\/j.mam.2020.100870_bib302","doi-asserted-by":"crossref","DOI":"10.4161\/onci.26442","article-title":"The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8(+) T cells into innate-like effector cells with antitumor activity","volume":"2","author":"Wong","year":"2013","journal-title":"OncoImmunology"},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib303","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clim.2013.02.007","article-title":"Elevated serum IL-22 levels correlate with chemoresistant condition of colorectal cancer","volume":"147","author":"Wu","year":"2013","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.mam.2020.100870_bib304","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.intimp.2015.09.017","article-title":"Increased Tim-3 expression in peripheral NK cells predicts a poorer prognosis and Tim-3 blockade improves NK cell-mediated cytotoxicity in human lung adenocarcinoma","volume":"29","author":"Xu","year":"2015","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib305","first-page":"64","article-title":"A\u00a0novel CD7 chimeric antigen receptor-modified NK-92MI cell line targeting T-cell acute lymphoblastic leukemia","volume":"9","author":"You","year":"2019","journal-title":"Am. J. Canc. Res."},{"issue":"12","key":"10.1016\/j.mam.2020.100870_bib306","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","article-title":"Location and cellular stages of natural killer cell development","volume":"34","author":"Yu","year":"2013","journal-title":"Trends Immunol."},{"issue":"5","key":"10.1016\/j.mam.2020.100870_bib307","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv375","article-title":"ErbB2\/HER2-Specific NK cells for targeted therapy of glioblastoma","volume":"108","author":"Zhang","year":"2016","journal-title":"J.\u00a0Natl. Cancer Inst."},{"issue":"7","key":"10.1016\/j.mam.2020.100870_bib308","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41590-018-0132-0","article-title":"Blockade of the checkpoint receptor TIGIT prevents NK cell exhaustion and elicits potent anti-tumor immunity","volume":"19","author":"Zhang","year":"2018","journal-title":"Nat. Immunol."},{"issue":"4","key":"10.1016\/j.mam.2020.100870_bib309","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.4049\/jimmunol.1203034","article-title":"Cutting edge: antibody-dependent memory-like NK cells distinguished by FcRgamma deficiency","volume":"190","author":"Zhang","year":"2013","journal-title":"J.\u00a0Immunol."},{"issue":"1","key":"10.1016\/j.mam.2020.100870_bib310","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12967-019-1917-0","article-title":"TNF-alpha-induced Tim-3 expression marks the dysfunction of infiltrating natural killer cells in human esophageal cancer","volume":"17","author":"Zheng","year":"2019","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.mam.2020.100870_bib311","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.3389\/fimmu.2018.02821","article-title":"Intrinsic expression of immune checkpoint molecule TIGIT could help tumor growth in\u00a0vivo by suppressing the function of NK and CD8(+) T cells","volume":"9","author":"Zhou","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299720300297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T09:44:42Z","timestamp":1778665482000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299720300297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":311,"alternative-id":["S0098299720300297"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2020.100870","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NK cells and ILCs in tumor immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2020.100870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100870"}}